Due to its unique physicochemical properties and remarkable antimicrobial activity, nanosilver (nAg) is increasingly being used in a wide array of fields, including medicine and personal care products. Despite substantial progress being made towards the understanding of the acute toxicity of nAg, large knowledge gaps still exist on the assessment of its chronic toxicity to humans. Chronic effects of nAg, typically at low doses (i.e. sublethal doses) should be different from the acute toxicity at high doses (i.e., lethal doses), which is analogous to other environmental pollutants. Although a few review papers have elaborated the findings on nAg-mediated toxicity, most of them only discussed overt toxicity of nAg at high-level exposure and failed to evaluate the chronic and cumulative effects of nAg at sublethal doses. Therefore, it is necessary to more stringently scrutinize the sublethal toxicity of nAg under environmentally relevant conditions. Herein, we recapitulated recent findings on the sublethal effects of nAg toxicity performed by our groups and others. We then discussed the molecular mechanisms by which nAg exerts its toxicity under low concentrations and compared that with nAg-induced cell death.

Breast cancer is the fifth most common cause of cancer death in the world and the second most common fatal cancer in women. Epidemiological studies and clinical data have indicated that hormones, including estrogen, progesterone, and prolactin, play important roles in the initiation and progression of breast cancer. Bisphenol A (BPA) is one of the most commonly used and thoroughly studied endocrine disruptors. It can be released from consumer products and deposited in the environment, thus creating potential for human exposure through oral, inhaled, and dermal routes. Some recent reviews have summarized the known mechanisms of endocrine disruptions by BPA in human diseases, including obesity, reproductive disorders, and birth defects. However, large knowledge gaps still exist on the roles BPA may play in cancer initiation and development. Evidence from animal and in vitro studies has suggested an association between increased incidence of breast cancer and BPA exposure at doses below the safe reference doses that are the most environmentally relevant. Most current studies have paid little attention to the cancer‐promoting properties of BPA at low doses. In this review, recent findings on the carcinogenic effects of low‐dose BPA on breast cancer and discussed possible biologic mechanisms are summarized.